Early research (Phase 1)Study completedNCT04408963What this trial is testingTrial to Evaluate CAP256V2LS in Healthy AdultsWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT04033887What this trial is testingEvaluation Study of RDTs Detecting Antibodies Against HCVWho this might be right forHepatitis C Foundation for Innovative New Diagnostics, Switzerland 1,710
Not applicableStudy completedNCT06368453What this trial is testingEvaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-TestWho this might be right forHuman Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection bioLytical Laboratories 1,728
Early research (Phase 1)Study completedNCT00027365What this trial is testingAn Investigational Combination Vaccine Given to People Who Are Not Infected With HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT00886964What this trial is testingHepatitis B Vaccination (HBV) in HIV Infected ChildrenWho this might be right forHIV Infections The HIV Netherlands Australia Thailand Research Collaboration 80
Not applicableLooking for participantsNCT07089836What this trial is testingThis Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.Who this might be right forTreponema PallidumTreponema Pallidum InfectionSyphilis Infection+4 more American Laboratory Products Company 1,000
Not applicableStudy completedNCT04810559What this trial is testingNear Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole BloodWho this might be right forHIV TestingHIV Infections Unity Health Toronto 600
Early research (Phase 1)Study completedNCT01378156What this trial is testingA Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ARTWho this might be right forHIV-1 Infection GeoVax, Inc. 9
Not applicableStudy completedNCT02190578What this trial is testingClinical Performance of Reveal G4 Rapid HIV-1 Antibody TestWho this might be right forHIV Infections MedMira Laboratories Inc. 1,649
Testing effectiveness (Phase 2)Study completedNCT00011037What this trial is testingALVAC-HIV vCP1452 Alone and Combined With MN rgp120Who this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 160
Early research (Phase 1)Study completedNCT00000886What this trial is testingA Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Study completedNCT00514605What this trial is testingTesting of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV InfectionWho this might be right forHIV Infections bioLytical Laboratories 2,500
Large-scale testing (Phase 3)UnknownNCT00999739What this trial is testingConjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected AdultsWho this might be right forPneumococcal VaccinesHIVHIV Infections Hospital Universitari Son Dureta 220
Early research (Phase 1)Study completedNCT04723602What this trial is testingEvaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsWho this might be right forEbola Virus DiseaseMarburg Virus Disease Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)Ended earlyNCT03565315What this trial is testingPhase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy AdultsWho this might be right forHealthy Adult Immune Response National Institute of Allergy and Infectious Diseases (NIAID) 9
Testing effectiveness (Phase 2)Ended earlyNCT00865566What this trial is testingSafety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With MenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Not applicableStudy completedNCT01447680What this trial is testingComparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingWho this might be right forHuman Immunodeficiency Virus InfectionHepatitis C G & W Laboratories Inc. 1,600
Testing effectiveness (Phase 2)Study completedNCT01412801What this trial is testingMagnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their OffspringsWho this might be right forStreptococcal InfectionsGram-Positive Bacterial InfectionsBacterial Infections Novartis Vaccines 270
Not applicableStudy completedNCT01317784What this trial is testingBehavioral Science Aspects of Rapid Test AcceptanceWho this might be right forHIVHepatitis CHepatitis B+1 more California State University, Long Beach 1,200
Not applicableStudy completedNCT00006298What this trial is testingStudies of HIV-1 Infection in Newly Infected Individuals in Southern AfricaWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 125